Posted on 11/16/20
This Is What a Comcast-Walmart TV Partnership Would Really Be About
Cable giant Comcast (NASDAQ:CMCSA) and retailer Walmart (NYSE:WMT) may be teaming up to make television sets, according to recent reports from The Wall Street Journal.Neither company . . .
Posted on 11/16/20
Why You Shouldn't Ignore Johnson & Johnson
The year 2020 has been full of surprises. Growth stocks, which are usually the first to get battered during economic downturns, have performed exceptionally well, while . . .
Posted on 11/16/20
These 3 Stocks Rallied 10% After Pfizer's Vaccine News: Here's Why They're Still Buys
Pfizer's Nov. 9 announcement that it's making progress toward a COVID-19 vaccine caused markets to rally, with beaten down sectors including airlines, industrials, and retailers leading . . .
Posted on 11/16/20
Here's Why Pfizer's Coronavirus Vaccine Would Be Revolutionary
Fool.com's Healthcare and Cannabis Bureau Chief Corinne Cardina interviewed Richard Horton on Motley Fool Live on Oct. 9. Horton runs the British medical journal The Lancet . . .
Posted on 11/16/20
The Biggest Takeaway From Pfizer's Coronavirus Vaccine Results
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) created a firestorm (in a good way) when they announced interim efficacy results for their coronavirus vaccine candidate BNT162b2 last Monday. Motley Fool . . .
Posted on 11/13/20
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
CRANBURY, N.J., Nov. 13, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic . . .
Posted on 11/13/20
Pfizer CEO Sold Shares on Same Day as the Company's Coronavirus Vaccine News: Should You Be Outraged?
This seems like another story of the greed of corporate executives, at least at first glance. On Monday, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced exciting news. . . .
Posted on 11/12/20
TYME Provides Business Update and Announces Second Quarter Fiscal 2021 Financial and Operating Results
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced financial and operating results for its second quarter ended . . .
Posted on 11/12/20
Akers Biosciences and MyMD Pharmaceuticals Merges
MyMD Pharmaceuticals, Inc. and Akers Biosciences, Inc. (NASDAQ: AKER) today jointly announced that they have entered into a definitive merger agreement.
Posted on 11/12/20
Osmotica Pharmaceuticals plc Reports Third Quarter 2020 Results and Provides Business Updates
BRIDGEWATER, N. J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced business highlights and financial results . . .
Posted on 11/12/20
J. Knipper and Company to Acquire Eagle Pharmacy
LAKEWOOD, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- J. Knipper and Company, Inc., one of the largest suppliers of end-to-end pharmaceutical healthcare marketing services and solutions . . .
Posted on 11/12/20
TELA Bio Announces Third Quarter 2020 Financial Results
MALVERN, Pa., Nov. 11, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new . . .
Posted on 11/12/20
PDS Biotechnology Reports Financial Results for the Third Quarter 2020 and Provides Business Update
FLORHAM PARK, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines . . .
Posted on 11/12/20
Cyclacel Pharmaceuticals Reports Third Quarter 2020 Financial Results
BERKELEY HEIGHTS, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company developing innovative medicines based on cancer cell . . .
Posted on 11/12/20
Pfizer's Coronavirus Vaccine Data Is Better Than Meets the Eye
As of Tuesday, there have been more than 50.9 million confirmed cases of the novel coronavirus worldwide, and 1.26 million deaths. In the U.S. alone, researchers . . .
Posted on 11/12/20
Could Pfizer Be a Millionaire-Maker Stock?
When Albert Bourla assumed the role of chairman and chief executive officer at Pfizer (NYSE:PFE) at the beginning of 2019, he moved quickly to create a . . .
Posted on 11/10/20
Passage Bio Reports Third Quarter 2020 Financial Results and Recent Business Highlights
PHILADELPHIA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous . . .
Posted on 11/10/20
Galera Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates
MALVERN, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, . . .
Posted on 11/10/20
Cabaletta Bio Reports Third Quarter 2020 Financial Results and Provides Business Update
PHILADELPHIA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell . . .
Posted on 11/10/20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
BALA CYNWYD, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Nasdaq:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today . . .
Posted on 11/10/20
Coronavirus Vaccine Candidate From Pfizer and BioNTech Leaps Over Efficacy Hurdle
Buck up campers, it might all be over soon. On Monday morning, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced success with their coronavirus vaccine candidate, BNT162b2, following . . .
Posted on 11/10/20
Pfizer Vaccine News Pumps Up Oil Prices
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced this morning that their coronavirus vaccine candidate BNT162b2 is showing 90% effectiveness in phase 3 clinical trials. The companies are . . .
Posted on 11/10/20
Why Inovio Pharmaceuticals, Novavax, and Vaxart Crashed in October
What happenedDevelopmental-stage COVID-19 vaccine stocks continued their recent downward trend last month. Over the course of October, for instance, Inovio Pharmaceuticals (NASDAQ:INO) lost 16.1% of its . . .
Posted on 11/10/20
Marinus Pharmaceuticals Provides Business Update
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today provided an update . . .
Posted on 11/9/20
UroGen Pharma Reports Third Quarter 2020 Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced . . .
Philadelphia
